Pharmasset (VRUS) Posts Mixed Q211 Results; Loss Narrower than Expected
Tweet
Share
E-mailGet Alerts VRUS Hot Sheet
Join SI Premium – FREE
Pharmasset, Inc. (Nasdaq: VRUS) reported Q2 loss of $0.55, $0.10 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $247 thousand versus the consensus estimate of $440 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
